"10.1371_journal.pone.0089990","plos one","2014-03-19T00:00:00Z","Lamiae Grimaldi-Bensouda; Bernard B√©gaud; Michel Rossignol; Bernard Avouac; France Lert; Frederic Rouillon; Jacques B√©nichou; Jacques Massol; Gerard Duru; Anne-Marie Magnier; Lucien Abenhaim; Didier Guillemot","LA-SER, Paris, France; Pharmacoepidemiology and Infectious Diseases Research Group, Pasteur Institute, Paris, France; INSERM U657, University of Bordeaux Segalen, U657, Bordeaux, France; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada; LA-SER Center for Risk Research, Montreal, Canada; INSERM U1018, Center for Epidemiology and Population Health, Villejuif, France; Sainte-Anne Hospital, University of Paris V Ren√© Descartes, Paris, France; INSERM U657, Pharmacoepidemiology and evaluation of the impact of health products on human health, Department of Pharmacology, University Victor Segalen Bordeaux 2, Tondu Hospital ‚Ä Case 41, Bordeaux, France; Department of Biostatistics, University Hospital of Rouen, Rouen, France; Faculty of Medicine, University of Franche Comt√©, Besan√ßon, France; Cyklad Group, Rillieux la Pape, France; Faculty of Medicine, University Pierre and Marie Curie, Paris, France; Department of Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom; LA-SER Europe Limited, London, United Kingdom; Pasteur Institute, Paris, France; Faculty of Medicine, University of Paris-Ile de France Ouest, Guyancourt, Paris, France","Conceived and designed the experiments: LG-B BB MR BA FL FR JB JM GD A-MM LA DG. Performed the experiments: LG-B. Analyzed the data: LG-B MR DG. Wrote the paper: MR DG. Developed and approved the study protocol and the analyses plan: LG-B BB MR BA FL FR JB JM GD A-MM LA DG. Discussed and interpreted the results: LG-B BB MR BA FL FR JB JM GD A-MM LA DG. Revised the manuscript: LG-B BB MR BA FL FR JB JM GD A-MM LA DG.","The authors have the following interests: LGB, BA and MR are employees of LA-SER, the company conducting the study. LG-B was the recipient of a research fellowship from INSERM (French National Institute of Health and Medical Research) at the time of the study. LA is a stockholder in LA-SER. GD is employed by Cyklad Group. FR and DG received a consulting fee or honorarium from LA-SER for the submitted work. This study was funded by Laboratoires Boiron, France. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2014","03","Lamiae Grimaldi-Bensouda","LGB",12,TRUE,12,1,3,2,TRUE,TRUE,FALSE,0,NA,FALSE
